US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

265.95

-13.0700-4.68%

Volume:183.14K

Turnover:49.06M

Market Cap:498.52M

PE:- -

High:274.71

Open:265.00

Low:260.01

Close:279.02

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:1.76

T/O Rate:9.77%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures

Health Care Roundup: Market Talk

HealthCo REIT Director Increases Stake Under Board Unit Plan

Fisher & Paykel Healthcare Issues New Unquoted Employee Options

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett

EBR Systems Says FDA Finds No Need for WiSE System Recall After Cybersecurity Incident

MT Newswires Live

Press Release: Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting

Echo IQ's EchoSolv HF Device Deemed 'Not Substantially Equivalent' by US FDA

MT Newswires Live

Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup

Tenet Healthcare Prices Upsized $2 Billion Notes Offering

MT Newswires Live

Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference

Health Care Roundup: Market Talk

Intellia’s Lonvo-z Gains FDA Priority Review for HAE

Cycurion Secures New Healthcare and Public Health Contracts

Analyst Maintains Buy on Sarepta, Keeping $35 Price Target Amid Confidence in DM1 Franchise and α‑Integrin Delivery Platform

ICU Girişim Sermayesi Details Diversified Venture Portfolio in Healthcare and Technology

Dennis Ding Reiterates Buy on Tarsus, Highlighting Robust Xdemvy Trends, Conservative 2026 Guidance, and Attractive Valuation Backed by Late-Stage Pipeline

Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), BioCryst (BCRX)

Analysts Are Bullish on These Healthcare Stocks: enGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/LABU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":265.95,"timestamp":1789054847690,"preClose":279.02,"halted":0,"volume":183144,"delay":0,"changeRate":-0.046842520249444464,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Trading","change":-13.07,"latestTime":"09-10 11:41:05 EDT","open":265,"high":274.705,"low":260.01,"amount":49061643.98928,"amplitude":0.052666,"askPrice":266.86,"askSize":40,"bidPrice":266.21,"bidSize":14,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":279.02,"sharesOutstanding":3074486,"nav":292.443,"aum":548181239.8,"dividendRate":0.003777,"bidAskSpread":0.003029,"preHourTrading":{"tag":"盘前","latestPrice":268.99,"preClose":279.02,"latestTime":"09:29 EDT","volume":1828,"amount":503835.0052,"timestamp":1789046962415,"change":-10.03,"changeRate":-0.035947,"amplitude":0.054249},"postHourTrading":{"tag":"盘后","latestPrice":278.58,"preClose":279.02,"latestTime":"19:59 EDT","volume":5408,"amount":1506106.6336,"timestamp":1788998373887,"change":-0.44,"changeRate":-0.001577,"amplitude":0.005304},"volumeRatio":1.761199,"impliedVol":0.9197,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.761199,"shares":1874486,"dividePrice":1.0045,"high":274.705,"amplitude":0.052666,"preClose":279.02,"low":260.01,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":265.95,"committee":-0.481481,"eps":0,"divideRate":0.003777,"volume":183144,"delay":0,"ttmEps":0,"open":265,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":311.81,"twentyDayClose":286.75,"sixtyDayClose":188.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666589965","title":"Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589965","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589965?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:11","pubTimestamp":1788945080,"startTime":"0","endTime":"0","summary":"Bamboos Health Care Holdings Ltd ( ($HK:2293) ) has issued an update. Bamboos Health Care Holdings Ltd has issued a profit warning, indicating net ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-warns-of-sharp-profit-decline-amid-competitive-and-cost-pressures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-warns-of-sharp-profit-decline-amid-competitive-and-cost-pressures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","XBI","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666158565","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666158565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666158565?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:20","pubTimestamp":1788942000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0801 GMT - Novartis's latest clinical-trial setback raises quest","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","BK4585","XBI","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666588523","title":"HealthCo REIT Director Increases Stake Under Board Unit Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666588523","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666588523?lang=en_us&edition=fundamental","pubTime":"2026-09-09 15:08","pubTimestamp":1788937697,"startTime":"0","endTime":"0","summary":"An announcement from HealthCo Healthcare & Wellness REIT ( ($AU:HCW) ) is now available. HealthCo Healthcare & Wellness REIT disclosed a change in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthco-reit-director-increases-stake-under-board-unit-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthco-reit-director-increases-stake-under-board-unit-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFRA","XBI","BK4588","RNTY","IVRA","YLDW","BPRE","PSCF","XLV","IQRA","LABU","BK4581","REIT","RJMG","BK4585","MDIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530127","title":"Fisher & Paykel Healthcare Issues New Unquoted Employee Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530127?lang=en_us&edition=fundamental","pubTime":"2026-09-09 11:17","pubTimestamp":1788923854,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) just unveiled an update. Fisher & Paykel Healthcare Corporation Limited has notified t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-issues-new-unquoted-employee-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-issues-new-unquoted-employee-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FPH.NZ","BK4588","BK8004","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630973","title":"Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630973?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:30","pubTimestamp":1788921013,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE0009355771.USD","LU0868494617.USD","XLV","BEAM","LU1983299246.USD","LU0889565916.HKD","LU2112291526.USD","BK4611","PBE","SG9999001440.SGD","BBH","BIB","IE00B4R5TH58.HKD","LU1861558580.USD","LU2242652126.USD","TBXU","BK4588","XBI","IE00B2B36J28.USD","LABU","RPRX","IE0002141913.USD","LU1061106388.HKD","BK4599","BK4137","AMGN","IE00BFTCPJ56.SGD","IBBQ","BK4505","LU1023059063.AUD","IE00BJT1NW94.SGD","PJP","LU2242646821.SGD","IHE","LU0109394709.USD","BK4535","LU0029874061.USD","BK4533","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0320765992.SGD","IBB","BK4566","LU1861559042.SGD","LU2468319806.SGD","BK4534","HCSG","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309940","title":"Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309940?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:06","pubTimestamp":1788919570,"startTime":"0","endTime":"0","summary":"Ord Minnett analyst maintained a Sell rating on Ramsay Health Care today and set a price target of A$48.00. In addition to Ord Minnett, Ramsay Heal...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-sell-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-sell-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","BK4585","BK4581","BK4588","XBI","RMSYF","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630529","title":"EBR Systems Says FDA Finds No Need for WiSE System Recall After Cybersecurity Incident","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630529","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630529?lang=en_us&edition=fundamental","pubTime":"2026-09-09 09:02","pubTimestamp":1788915728,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration  has completed its review of the company's cybersecurity risk assessment related to the February incident and determined that no field corrective action or recall of the WiSE System is warranted, according to a Wednesday filing with the Australian bourse.The incident was classified as a controlled risk under FDA postmarket cybersecurity guidance, with no evidence of any impact on the safety or performance of fielded WiSE cardiac resynchronization therapy systems, per the filing.The company continues its cybersecurity remediation efforts by strengthening credential controls, enhancing anti-phishing measures, expanding endpoint monitoring, hardening its products, and providing required updates to the FDA, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","NTSK","HAKY","BUG","BK4097","EBR.AU","TEKX","BK4588","CIBR","LABU","HACK","BK7007","IHAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370726","title":"Press Release: Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370726?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:59","pubTimestamp":1788904740,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. (OTCQB: INTI) (\"Inhibitor\" or the \"Company\") today highlighted several important developments disclosed in its Quarterly Re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","BK4022","BK4588","BK4539","BK4139","R","BK4232","INTI","LENZ","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370799","title":"Echo IQ's EchoSolv HF Device Deemed 'Not Substantially Equivalent' by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370799","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370799?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:58","pubTimestamp":1788904705,"startTime":"0","endTime":"0","summary":"Echo IQ  failed to secure commercial clearance for its EchoSolv HF device after the US Food and Drug Administration  found its initial 510 application  \"not substantially equivalent,\" according to an Australian bourse filing on Tuesday after market hours.The company is evaluating the US FDA's concerns with regulatory, legal, and statistical advisers and believes a potential pathway to clearance remains, per the filing.An applicant whose medical device has been deemed not substantially equivalent may resubmit another 510 application with new data, request a Class I or II designation, file a reclassification petition, or submit a premarket approval application, according to the FDA's website.The decision does not affect the FDA-cleared EchoSolv AS platform or its commercialization in the US, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","EIQ.AU","BK7016","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666704053","title":"Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666704053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666704053?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:31","pubTimestamp":1788903060,"startTime":"0","endTime":"0","summary":"Health-care companies fell after growth warnings from two major medical-device makers and a disappointing clinical trial.Shares of Novartis plunged after one of the company's leading drug candidates failed to show significant progress on a late-stage trial on sufferers of a neuromuscular condition.Medical-device maker Boston Scientific said it likely would not meet its financial guidance due to the cyberattack that has disrupted its operations.Shares of Stryker declined after the maker of orthopedic implants and other medical technology said a lack of supply continues to hamper its peripheral vascular business.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","LU2362541513.USD","IE00B2B36J28.USD","LU0225283273.USD","LU1291159041.SGD","BK4585","IE0009355771.USD","LU1983299246.USD","LU0267386448.USD","BK4504","XBI","SG9999001176.SGD","LU2324357040.USD","LU1023059063.AUD","LU2506951958.HKD","LU2362540622.SGD","BK4581","IE00B4R5TH58.HKD","LU1989764664.SGD","LU2357305700.SGD","BSX","LU0122379950.USD","LU0251132253.USD","LU0353189680.USD","LU1720051108.HKD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU0048584097.USD","LU1791710400.SGD","IE00BJT1NW94.SGD","LU1153585028.USD","LU2491050071.SGD","LABU","LU1791710582.SGD","SGXZ57979304.SGD","LU0138981039.USD","LU0823417737.USD","LU2242649171.HKD","LU1548497426.USD","LU0345769631.USD","LU1989771016.USD","LU0238689110.USD","LU0882574055.USD","LU2491049909.HKD","LU0266013472.USD","LU0823417653.USD","LU0187121727.USD","BK4082","LU1989764748.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370464","title":"Tenet Healthcare Prices Upsized $2 Billion Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370464","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370464?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:28","pubTimestamp":1788902911,"startTime":"0","endTime":"0","summary":"Tenet Healthcare  priced a private offering of $2 billion in senior notes due Sept. 15, 2034, bearing interest at 6.250% per annum, the company said late Tuesday.The offering was upsized from a previously announced $1.5 billion, with completion expected Sept. 22, the company said.Tenet said proceeds, along with cash on hand, will fund redemption of $1.5 billion of its 5.125% notes due 2027 and partial redemption of $500 million of its 6.125% notes due 2028.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","LABU","XLV","BK4588","LU0130103400.USD","BK4585","LU0648000940.SGD","HCSG","BK4185","BK4137","THC.AU","XBI","LU1201861165.SGD","LU0029874061.USD","THC","LU0128526141.USD","LU0963586101.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666689370","title":"Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666689370","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666689370?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:05","pubTimestamp":1788901500,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 2026 Jefferies Healthcare Ser","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3358168/0/en/strata-critical-to-present-at-the-2026-jefferies-healthcare-services-and-technology-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LABU","BK4585","HCSG","BK4581","XLV","BK4588","LU0029874061.USD","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370898","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370898?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:50","pubTimestamp":1788900600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0417 ET - Novartis's latest clinical-trial failure suggests the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LABU","XLV","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666772143","title":"Intellia’s Lonvo-z Gains FDA Priority Review for HAE","url":"https://stock-news.laohu8.com/highlight/detail?id=2666772143","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666772143?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:35","pubTimestamp":1788899708,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics ( ($NTLA) ) has shared an update. On September 8, 2026, Intellia Therapeutics announced that the U.S. Food and Drug Administr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intellias-lonvo-z-gains-fda-priority-review-for-hae?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intellias-lonvo-z-gains-fda-priority-review-for-hae?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1169589451.USD","BK4585","LABU","IE0034390439.USD","LU0106261612.USD","IE00B64QTZ34.USD","LU0205193047.USD","BK4588","LU1169590202.USD","LU0205194284.USD","IE00BLDYK493.USD","BK4198","HAE","IE00B19Z6F94.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372275","title":"Cycurion Secures New Healthcare and Public Health Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372275","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372275?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:47","pubTimestamp":1788896876,"startTime":"0","endTime":"0","summary":"Cycurion ( ($CYCU) ) has shared an update. On September 3, 2026, Cycurion announced new engagements totaling about $800,000 in annual contract spen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cycurion-secures-new-healthcare-and-public-health-contracts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cycurion-secures-new-healthcare-and-public-health-contracts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LABU","BK4137","BK4585","CYCU","HCSG","XBI","LU0029874061.USD","XLV","BK4581","BK4123","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372293","title":"Analyst Maintains Buy on Sarepta, Keeping $35 Price Target Amid Confidence in DM1 Franchise and α‑Integrin Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372293","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372293?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:45","pubTimestamp":1788896725,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yun Zhong from Wedbush maintained a Buy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-sarepta-keeping-35-price-target-amid-confidence-in-dm1-franchise-and-integrin-delivery-platform-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-sarepta-keeping-35-price-target-amid-confidence-in-dm1-franchise-and-integrin-delivery-platform-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666273374","title":"ICU Girişim Sermayesi Details Diversified Venture Portfolio in Healthcare and Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666273374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666273374?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:12","pubTimestamp":1788891143,"startTime":"0","endTime":"0","summary":"ICU Girisim Sermayesi Yatirim Ortakligi A.S. ( ($TR:ICUGS) ) has provided an announcement. ICU Girişim Sermayesi Yatırım Ortaklığı A.Ş. has detaile...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icu-girisim-sermayesi-details-diversified-venture-portfolio-in-healthcare-and-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icu-girisim-sermayesi-details-diversified-venture-portfolio-in-healthcare-and-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","XLV","LABU","HCSG","BK4585","BK4588","LU0128526141.USD","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374136","title":"Dennis Ding Reiterates Buy on Tarsus, Highlighting Robust Xdemvy Trends, Conservative 2026 Guidance, and Attractive Valuation Backed by Late-Stage Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374136?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:55","pubTimestamp":1788890117,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Dennis Ding from Jefferies reiterated ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/dennis-ding-reiterates-buy-on-tarsus-highlighting-robust-xdemvy-trends-conservative-2026-guidance-and-attractive-valuation-backed-by-late-stage-pipeline-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/dennis-ding-reiterates-buy-on-tarsus-highlighting-robust-xdemvy-trends-conservative-2026-guidance-and-attractive-valuation-backed-by-late-stage-pipeline-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","LABU","TARS","XLV","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374637","title":"Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), BioCryst (BCRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374637?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:20","pubTimestamp":1788888012,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and BioCryst (BCRX) with b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-spyre-therapeutics-syre-biocryst-bcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-spyre-therapeutics-syre-biocryst-bcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XLV","LU0128526141.USD","HCSG","BK4547","BK4588","LU0029874061.USD","SYRE","BK4585","LABU","XBI","LFSC","BCRX","BK4137","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666275371","title":"Analysts Are Bullish on These Healthcare Stocks: enGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666275371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666275371?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:40","pubTimestamp":1788885608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on enGene Holdings (ENGN) and Structure Therapeutics, I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-engene-holdings-engn-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-engene-holdings-engn-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HCSG","BK4599","SAPH","XLV","DIVL","LU0128526141.USD","AADR","XBI","ENGN","CVY","LU0029874061.USD","BK4588","BK4137","ARMH","BK4581","BK4585","LABU","DINT","GPCR","BK4139","APIE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":4,"totalSize":412,"code":"91000000","status":"200"}]}}